Depixus® is a fast-growing innovative biotechnology company based in Paris, France, and is pioneering a powerful new technology based on magnetic force spectroscopy, that reveals biomolecular interactions. MAGNA™ enables researchers to decode disease mechanisms and unlock a faster route to more effective therapies.
Depixus SAS
3-5 Impasse Reille
Paris, Ile-de-France 75014
France